Quality of life in patients with advanced ovarian cancer under personalised treatment: the impact of HIPEC
Ovarian cancer ranks first among gynaecological cancers in terms of mortality, mainly due to late detection and high recurrence rates. The standard treatment for late stages remains cytoreductive surgery combined with systemic chemotherapy. However, survival and quality of life for patients receivi...
Saved in:
| Main Authors: | V. Maksymovskyi, A. Rybin, V. Zamyshlyak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kazimierz Wielki University
2025-08-01
|
| Series: | Journal of Education, Health and Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/JEHS/article/view/64751 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalised treatment of patients with advanced ovarian cancer: comparative analysis of surgical approaches
by: A. Rybin, et al.
Published: (2025-06-01) -
Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
by: M. V. Zabelin, et al.
Published: (2022-06-01) -
Evaluation of the antitumour activity of local intraperitoneal hyperthermia in a model of advanced high-grade ovarian carcinoma in rats
by: Ya. G. Murazov, et al.
Published: (2022-01-01) -
Textbook outcome in ovarian cancer and its impact on survival: comparative study
by: Silvia Carbonell-Morote, et al.
Published: (2025-02-01) -
Feasibility of a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Program for Gastrointestinal and Gynecological Cancer Care in Newfoundland and Labrador
by: Kala Hickey, et al.
Published: (2025-04-01)